3-(4-(3-(4-methylpiperazin-1-yl)propoxy)phenyl)-5-(4-(4-nitrophenoxy)benzylidene)-2-thioxothiazolidin-4-one

ID: ALA3765155

Chembl Id: CHEMBL3765155

PubChem CID: 71656031

Max Phase: Preclinical

Molecular Formula: C30H30N4O5S2

Molecular Weight: 590.73

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc([N+](=O)[O-])cc5)cc4)SC3=S)cc2)CC1

Standard InChI:  InChI=1S/C30H30N4O5S2/c1-31-16-18-32(19-17-31)15-2-20-38-25-11-5-23(6-12-25)33-29(35)28(41-30(33)40)21-22-3-9-26(10-4-22)39-27-13-7-24(8-14-27)34(36)37/h3-14,21H,2,15-20H2,1H3/b28-21-

Standard InChI Key:  IPXRZZWLNNGCCT-HFTWOUSFSA-N

Associated Targets(Human)

IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ikbkb Inhibitor of nuclear factor kappa-B kinase subunit beta (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 590.73Molecular Weight (Monoisotopic): 590.1658AlogP: 5.81#Rotatable Bonds: 10
Polar Surface Area: 88.39Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 5.83CX LogD: 5.04
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.10Np Likeness Score: -1.61

References

1. Kim D, Kim YG, Seo JH, Shin KJ..  (2016)  Identification and characterization of potent, selective and metabolically stable IKKβ inhibitor.,  26  (4): [PMID:26826731] [10.1016/j.bmcl.2016.01.065]

Source